Mode
Text Size
Log in / Sign up

Meta-analysis links soft drinks to higher IBD risk, alcohol, coffee, tea to lower riskSoft drinks linked to higher inflammatory bowel disease risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret these drink-IBD associations cautiously; they are observational and not causal.

This meta-analysis of observational studies synthesized evidence on the association between consumption of various drinks (soft beverages, alcohol, coffee, tea) and the risk of inflammatory bowel disease (IBD). The analysis pooled data from multiple studies, though specific study characteristics, sample sizes, and follow-up durations were not reported in the abstract.

Key findings showed that soft beverage intake was associated with an increased risk of IBD (OR = 1.144; 95% CI: 1.052–1.243; p = 0.002). In contrast, alcohol consumption (OR = 0.793; 95% CI: 0.629–0.999; p = 0.049), coffee intake (OR = 0.807; 95% CI: 0.667–0.976; p = 0.027), and tea intake (OR = 0.711; 95% CI: 0.522–0.970; p = 0.031) were each associated with a reduced risk of IBD. The authors noted a linear inverse dose-response for alcohol and coffee, but specific trends were not fully detailed.

Limitations include the observational nature of the included studies, precluding causal conclusions. The meta-analysis did not report on heterogeneity, publication bias, or adjustments for confounders. No safety data or practice relevance were provided.

Clinicians should interpret these associations cautiously. While the findings suggest potential dietary influences on IBD risk, they do not support recommending changes in drink consumption based solely on this evidence.

If you live with inflammatory bowel disease, or worry about it, what you drink matters. A new review of many studies found that people who drink more soft beverages have a higher risk of developing inflammatory bowel disease. The same review found that drinking coffee, tea, or alcohol was linked to a lower risk. The researchers combined data from many observational studies, but they could not prove that drinks cause or prevent the disease. They only found associations. The review did not report how many people were studied or for how long. It also did not report specific amounts of drinks or safety issues. Because the studies looked at habits over time, they cannot rule out other factors that might influence risk. Still, the patterns are consistent enough to pay attention to. For people managing inflammatory bowel disease, this adds a piece to the puzzle of daily choices. It does not mean you must change your habits, but it may help you talk with your doctor about what fits your life.

What this means for you:
Soft drinks may raise IBD risk, while coffee, tea, and alcohol may lower it, but the link is not proven.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
ObjectiveTo systematically review and synthesize the evidence between consumption of different drinks in daily life and the risk of Inflammatory bowel disease (IBD).MethodsWe systematically searched PubMed, Web of Science, SinoMed, Cochrane Library, Embase, Wiley, CNKI, and Wanfang Database for case–control, cohort, and cross-sectional studies investigating the relationship between beverage intake and IBD. A random-effects model was used for the meta-analysis.ResultsA total of 27 articles from 16 regions were included. The meta-analysis showed that soft beverage intake was associated with an increased risk of IBD (OR = 1.144, 95% CI: 1.052–1.243, p = 0.002). In contrast, alcohol intake (OR = 0.793, 95% CI: 0.629–0.999, p = 0.049), coffee intake (OR = 0.807, 95% CI: 0.667–0.976, p = 0.027), and tea intake (OR = 0.711, 95% CI: 0.522–0.970, p = 0.031) were associated with a reduced risk of IBD. Dose–response analysis revealed a linear inverse correlation between alcohol (linear trend p = 0.011) and coffee (linear trend p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.